GABAA receptor properties in catastrophic infantile epilepsy

Epilepsy Research

Volumn 81, Issue 2-3, 2008, Pages 188-197

  Jansen, Laura A ^a   Peugh, Lindsey D ^a   Ojemann, Jeffrey G ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cortical dysplasia; GABAA receptor; Human; Pediatric epilepsy; Pharmacotherapy; Voltage clamp

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BARBITURIC ACID DERIVATIVE; BICUCULLINE; CARBAMAZEPINE; CLONAZEPAM; CORTICOTROPIN; DIAZEPAM; ETIRACETAM; GANAXOLONE; LAMOTRIGINE; MIDAZOLAM; PENTOBARBITAL; PHENOBARBITAL; PICROTOXIN; PYRIDOXINE; TOPIRAMATE; ZINC; ZOLPIDEM; ZONISAMIDE;

ALTERNATIVE MEDICINE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN; BRAIN CORTEX; BRAIN TISSUE; CELL MEMBRANE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICAL DYSPLASIA; ELECTRODE; ELECTROPHYSIOLOGY; EPILEPSY; FEMALE; INFANTILE EPILEPSY; INFANTILE SPASM; INJECTION; INTRACTABLE EPILEPSY; MALE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; SAMPLE; TERMINAL DISEASE; TREATMENT RESPONSE; VOLTAGE CLAMP; XENOPUS;

5-ALPHA-DIHYDROPROGESTERONE; ANIMALS; BIOPHYSICS; BRAIN; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; FEMALE; GABA AGENTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; INFANT; MALE; MEMBRANE POTENTIALS; MICROINJECTIONS; PATCH-CLAMP TECHNIQUES; RECEPTORS, GABA-A; SPASMS, INFANTILE; XENOPUS LAEVIS; ZINC;

EID: 53249128949     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2008.05.011     Document Type: Article

References (66)

1. +-Cl-cotransporter, in epilepsy-associated malformations of cortical development. Neuroscience 145 (2007) 185-196
2. 2+ from brain tissue during activity. Nature 308 (1984) 734-736
3. Barish M.E. A transient calcium-dependent chloride current in the immature Xenopus oocyte. J. Physiol. 342 (1983) 309-325
4. Barnard E.A., Skolnick P., Olsen R.W., Mohler H., Sieghart W., Biggio G., Braestrup C., Bateson A.N., and Langer S.Z. International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50 (1998) 291-313
5. Belelli D., Casula A., Ling A., and Lambert J.J. The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors. Neuropharmacology 43 (2002) 651-661
6. Ben-Ari Y. Basic developmental rules and their implications for epilepsy in the immature brain. Epileptic Disord. 8 (2006) 91-102
7. Brooks-Kayal A.R., Shumate M.D., Jin H., Rikhter T.Y., and Coulter D.A. Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat. Med. 4 (1998) 1166-1172
8. Brooks-Kayal A.R., Shumate M.D., Jin H., Rikhter T.Y., Kelly M.E., and Coulter D.A. Gamma-aminobutyric acid(A) receptor subunit expression predicts functional changes in hippocampal dentate granule cells during postnatal development. J. Neurochem. 77 (2001) 1266-1278
9. Brunson K.L., Eghbal-Ahmadi M., and Baram T.Z. How do the many etiologies of West syndrome lead to excitability and seizures? The corticotropin releasing hormone excess hypothesis. Brain Dev. 23 (2001) 533-538
10. Buhl E.H., Otis T.S., and Mody I. Zinc-induced collapse of augmented inhibition by GABA in a temporal lobe epilepsy model. Science 271 (1996) 369-373
11. Calcagnotto M.E., Paredes M.F., Tihan T., Barbaro N.M., and Baraban S.C. Dysfunction of synaptic inhibition in epilepsy associated with focal cortical dysplasia. J. Neurosci. 25 (2005) 9649-9657
12. Cepeda C., Andre V.M., Levine M.S., Salamon N., Miyata H., Vinters H.V., and Mathern G.W. Epileptogenesis in pediatric cortical dysplasia: the dysmature cerebral developmental hypothesis. Epilepsy Behav. 9 (2006) 219-235
13. Cepeda C., Andre V.M., Wu N., Yamazaki I., Uzgil B., Vinters H.V., Levine M.S., and Mathern G.W. Immature neurons and GABA networks may contribute to epileptogenesis in pediatric cortical dysplasia. Epilepsia 48 Suppl. 5 (2007) 79-85
14. Cepeda C., Hurst R.S., Flores-Hernandez J., Hernandez-Echeagaray E., Klapstein G.J., Boylan M.K., Calvert C.R., Jocoy E.L., Nguyen O.K., Andre V.M., Vinters H.V., Ariano M.A., Levine M.S., and Mathern G.W. Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. J. Neurosci. Res. 72 (2003) 472-486
15. Cohen A.S., Lin D.D., Quirk G.L., and Coulter D.A. Dentate granule cell GABA(A) receptors in epileptic hippocampus: enhanced synaptic efficacy and altered pharmacology. Eur. J. Neurosci. 17 (2003) 1607-1616
16. Conry J.A. Pharmacologic treatment of the catastrophic epilepsies. Epilepsia 45 Suppl. 5 (2004) 12-16
17. Crino P.B., Duhaime A.C., Baltuch G., and White R. Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia. Neurology 56 (2001) 906-913
18. Crino P.B., Miyata H., and Vinters H.V. Neurodevelopmental disorders as a cause of seizures: neuropathologic, genetic, and mechanistic considerations. Brain Pathol. 12 (2002) 212-233
19. D'Agostino M.D., Bastos A., Piras C., Bernasconi A., Grisar T., Tsur V.G., Snipes J., Juhasz C., Chugani H., Guerrini R., Cross H., Andermann E., Dubeau F., Montes J., Olivier A., and Andermann F. Posterior quadrantic dysplasia or hemi-hemimegalencephaly: a characteristic brain malformation. Neurology 62 (2004) 2214-2220
20. Drafts B.C., and Fisher J.L. Identification of structures within GABAA receptor alpha subunits that regulate the agonist action of pentobarbital. J. Pharmacol. Exp. Ther. 318 (2006) 1094-1101
21. Dzhala V.I., Talos D.M., Sdrulla D.A., Brumback A.C., Mathews G.C., Benke T.A., Delpire E., Jensen F.E., and Staley K.J. NKCC1 transporter facilitates seizures in the developing brain. Nat. Med. 11 (2005) 1205-1213
22. Fritschy J.M., and Brunig I. Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharmacol. Ther. 98 (2003) 299-323
23. Gibbs III J.W., Morton L.D., Amaker B., Ward J.D., Holloway K.L., and Coulter D.A. Physiological analysis of Rasmussen's encephalitis: patch clamp recordings of altered inhibitory neurotransmitter function in resected frontal cortical tissue. Epilepsy Res. 31 (1998) 13-27
24. Gibbs III J.W., Shumate M.D., and Coulter D.A. Differential epilepsy-associated alterations in postsynaptic GABA(A) receptor function in dentate granule and CA1 neurons. J. Neurophysiol. 77 (1997) 1924-1938
25. Gibbs III J.W., Zhang Y.F., Kao C.Q., Holloway K.L., Oh K.S., and Coulter D.A. Characterization of GABAA receptor function in human temporal cortical neurons. J. Neurophysiol. 75 (1996) 1458-1471
26. Glauser T.A. Following catastrophic epilepsy patients from childhood to adulthood. Epilepsia 45 Suppl. 5 (2004) 23-26
27. Gonzalez-Martinez J.A., Gupta A., Kotagal P., Lachhwani D., Wyllie E., Luders H.O., and Bingaman W.E. Hemispherectomy for catastrophic epilepsy in infants. Epilepsia 46 (2005) 1518-1525
28. Gordey M., DeLorey T.M., and Olsen R.W. Differential sensitivity of recombinant GABA(A) receptors expressed in Xenopus oocytes to modulation by topiramate. Epilepsia 41 Suppl. 1 (2000) S25-29
29. Huang R.Q., and Dillon G.H. Maintenance of recombinant type A gamma-aminobutyric acid receptor function: role of protein tyrosine phosphorylation and calcineurin. J. Pharmacol. Exp. Ther. 286 (1998) 243-255
30. Jones-Davis D.M., and Macdonald R.L. GABA(A) receptor function and pharmacology in epilepsy and status epilepticus. Curr. Opin. Pharmacol. 3 (2003) 12-18
31. 2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J. Neurosci. 17 (1997) 7532-7540
32. Kapur J., and Macdonald R.L. Postnatal development of hippocampal dentate granule cell gamma-aminobutyric acid A receptor pharmacological properties. Mol. Pharmacol. 55 (1999) 444-452
33. Kerrigan J.F., Shields W.D., Nelson T.Y., Bluestone D.L., Dodson W.E., Bourgeois B.F., Pellock J.M., Morton L.D., and Monaghan E.P. Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial. Epilepsy Res. 42 (2000) 133-139
34. Leroy C., Poisbeau P., Keller A.F., and Nehlig A. Pharmacological plasticity of GABA(A) receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy. J. Physiol. 557 (2004) 473-487
35. Lettori, D., Battaglia, D., Sacco, A., Veredice, C., Chieffo, D., Massimi, L., Tartaglione, T., Chiricozzi, F., Staccioli, S., Mittica, A., Di Rocco, C., Guzzetta, F., 2007. Early hemispherectomy in catastrophic epilepsy A neuro-cognitive and epileptic long-term follow-up. Seizure.
36. Mackay M.T., Weiss S.K., Adams-Webber T., Ashwal S., Stephens D., Ballaban-Gill K., Baram T.Z., Duchowny M., Hirtz D., Pellock J.M., Shields W.D., Shinnar S., Wyllie E., and Snead III O.C. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 62 (2004) 1668-1681
37. Maguire J., and Mody I. Neurosteroid synthesis-mediated regulation of GABA(A) receptors: relevance to the ovarian cycle and stress. J. Neurosci. 27 (2007) 2155-2162
38. Marsal J., Tigyi G., and Miledi R. Incorporation of acetylcholine receptors and Cl-channels in Xenopus oocytes injected with Torpedo electroplaque membranes. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 5224-5228
39. Mathern G.W., Cepeda C., Hurst R.S., Flores-Hernandez J., Mendoza D., and Levine M.S. Neurons recorded from pediatric epilepsy surgery patients with cortical dysplasia. Epilepsia 41 Suppl. 6 (2000) S162-S167
40. Mercado A., de los Heros P., Vazquez N., Meade P., Mount D.B., and Gamba G. Functional and molecular characterization of the K-Cl cotransporter of Xenopus laevis oocytes. Am. J. Physiol. Cell Physiol. 281 (2001) C670-C680
41. Miledi R., Eusebi F., Martinez-Torres A., Palma E., and Trettel F. Expression of functional neurotransmitter receptors in Xenopus oocytes after injection of human brain membranes. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 13238-13242
42. Miledi R., Parker I., and Sumikawa K. Synthesis of chick brain GABA receptors by frog oocytes. Proc. R. Soc. Lond. B: Biol. Sci. 216 (1982) 509-515
43. Mtchedlishvili Z., Sun C.S., Harrison M.B., and Kapur J. Increased neurosteroid sensitivity of hippocampal GABAA receptors during postnatal development. Neuroscience 118 (2003) 655-666
44. Najm I., Ying Z., Babb T., Crino P.B., Macdonald R., Mathern G.W., and Spreafico R. Mechanisms of epileptogenicity in cortical dysplasias. Neurology 62 (2004) S9-S13
45. Najm I.M., Tilelli C.Q., and Oghlakian R. Pathophysiological mechanisms of focal cortical dysplasia: a critical review of human tissue studies and animal models. Epilepsia 48 Suppl. 2 (2007) 21-32
46. Palma E., Ragozzino D.A., Di Angelantonio S., Spinelli G., Trettel F., Martinez-Torres A., Torchia G., Arcella A., Di Gennaro G., Quarato P.P., Esposito V., Cantore G., Miledi R., and Eusebi F. Phosphatase inhibitors remove the run-down of gamma-aminobutyric acid type A receptors in the human epileptic brain. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 10183-10188
47. Palma E., Torchia G., Limatola C., Trettel F., Arcella A., Cantore G., Di Gennaro G., Manfredi M., Esposito V., Quarato P.P., Miledi R., and Eusebi F. BDNF modulates GABAA receptors microtransplanted from the human epileptic brain to Xenopus oocytes. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 1667-1672
48. Palma E., Trettel F., Fucile S., Renzi M., Miledi R., and Eusebi F. Microtransplantation of membranes from cultured cells to Xenopus oocytes: a method to study neurotransmitter receptors embedded in native lipids. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 2896-2900
49. Palmini A., Najm I., Avanzini G., Babb T., Guerrini R., Foldvary-Schaefer N., Jackson G., Luders H.O., Prayson R., Spreafico R., and Vinters H.V. Terminology and classification of the cortical dysplasias. Neurology 62 (2004) S2-8
50. Parker I., Gundersen C.B., and Miledi R. Actions of pentobarbital on rat brain receptors expressed in Xenopus oocytes. J. Neurosci. 6 (1986) 2290-2297
51. Ragozzino D., Palma E., Di Angelantonio S., Amici M., Mascia A., Arcella A., Giangaspero F., Cantore G., Di Gennaro G., Manfredi M., Esposito V., Quarato P.P., Miledi R., and Eusebi F. Rundown of GABA type A receptors is a dysfunction associated with human drug-resistant mesial temporal lobe epilepsy. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 15219-15223
52. Raol Y.H., Zhang G., Budreck E.C., and Brooks-Kayal A.R. Long-term effects of diazepam and phenobarbital treatment during development on GABA receptors, transporters and glutamic acid decarboxylase. Neuroscience 132 (2005) 399-407
53. Rigo J.M., Hans G., Nguyen L., Rocher V., Belachew S., Malgrange B., Leprince P., Moonen G., Selak I., Matagne A., and Klitgaard H. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br. J. Pharmacol. 136 (2002) 659-672
54. Riikonen R. The latest on infantile spasms. Curr. Opin. Neurol. 18 (2005) 91-95
55. Rogawski M.A., and Reddy D.S. Neurosteroids and infantile spasms: the deoxycorticosterone hypothesis. Int. Rev. Neurobiol. 49 (2002) 199-219
56. Rudolph U., and Mohler H. Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 475-498
57. Shen H., Gong Q.H., Yuan M., and Smith S.S. Short-term steroid treatment increases delta GABAA receptor subunit expression in rat CA1 hippocampus: pharmacological and behavioral effects. Neuropharmacology 49 (2005) 573-586
58. Shumate M.D., Lin D.D., Gibbs III J.W., Holloway K.L., and Coulter D.A. GABA(A) receptor function in epileptic human dentate granule cells: comparison to epileptic and control rat. Epilepsy Res. 32 (1998) 114-128
59. Simeone T.A., Wilcox K.S., and White H.S. Subunit selectivity of topiramate modulation of heteromeric GABA(A) receptors. Neuropharmacology 50 (2006) 845-857
60. 2+ ions: modulators of excitatory and inhibitory synaptic activity. Neuroscientist 10 (2004) 432-442
61. Thompson S.A., Whiting P.J., and Wafford K.A. Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination. Br. J. Pharmacol. 117 (1996) 521-527
62. Torres J.M., Ruiz E., and Ortega E. Effects of CRH and ACTH administration on plasma and brain neurosteroid levels. Neurochem. Res. 26 (2001) 555-558
63. Treiman D.M. GABAergic mechanisms in epilepsy. Epilepsia 42 Suppl. 3 (2001) 8-12
64. Wheless J.W. Nonpharmacologic treatment of the catastrophic epilepsies of childhood. Epilepsia 45 Suppl. 5 (2004) 17-22
65. White H.S., Brown S.D., Woodhead J.H., Skeen G.A., and Wolf H.H. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia 41 Suppl. 1 (2000) S17-20
66. Zhang G., Raol Y.H., Hsu F.C., Coulter D.A., and Brooks-Kayal A.R. Effects of status epilepticus on hippocampal GABAA receptors are age-dependent. Neuroscience 125 (2004) 299-303